Current practices in influenza management and barriers to influenza vaccination in Nepal

Authors

  • Ramesh Chokhani Department of Pulmonology, Norvic International Hospital, Kathmandu, Nepal

DOI:

https://doi.org/10.18203/2320-6012.ijrms20254398

Keywords:

Nepal, Influenza, Vaccination, Cost – effectiveness, Respiratory illness

Abstract

Influenza is a viral infection affecting the respiratory tract, resulting in substantial morbidity and mortality. This review article explores the current practices in influenza management and the barriers to vaccination in Nepal. Influenza-associated respiratory deaths account for approximately 2% of all respiratory deaths globally, with higher mortality rates in low to middle income countries (LMICs) like Nepal. Vaccination remains the most effective preventive measure, yet Nepal lacks a formal seasonal influenza vaccination policy, with vaccines available only in the private sector. Current practices emphasize early diagnosis and antiviral treatment within 48 hours of symptom onset, though delayed diagnosis and poor adherence to treatment guidelines are common in Nepal. The article also discusses the vulnerability of specific populations, including children, pregnant women, individuals with chronic medical conditions, the elderly, and healthcare workers. It underscores the need for improved vaccination coverage and policy changes to reduce influenza-related morbidity and mortality in Nepal. Despite the availability of vaccines, certain barriers limit access to vaccination especially in LMICs like Nepal despite established cost effectiveness of influenza vaccination. Targeted vaccination campaigns and public health education are essential to increase awareness and acceptance.

Metrics

Metrics Loading ...

References

Boktor SW, Hafner JW. Influenza. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Available at: https://www.ncbi.nlm.nih.gov/books/ NBK459363/. Accessed on 3 June 2025.

Paget J, Spreeuwenberg P, Charu V, Taylor RJ, Iuliano AD, Bresee J, et al. Global Seasonal Influenza-associated Mortality Collaborator Network and GLaMOR Collaborating Teams*. Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project. J Glob Health. 2019;9(2):020421. DOI: https://doi.org/10.7189/jogh.09.020421

WHO. Available at: https://www.emro.who.int/ health-topics/influenza/influenza-vaccines.html. Accessed on 03 June 2025.

Lafond KE, Porter RM, Whaley MJ, Suizan Z, Ran Z,AleemM.A.et.al.GlobalRespiratory Hospitalizations–Influenza Proportion Positive (GRIPP) Working Group. Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis. PLoS Med. 2021;18(3):e1003550. DOI: https://doi.org/10.1371/journal.pmed.1003550

GBD 2017 Influenza Collaborators. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2019;(1):69-89.

Coleman BL, Fadel SA, Fitzpatrick T, Thomas SM. Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis. Influenza Other Respir Viruses. 2018;12(1):22-29. DOI: https://doi.org/10.1111/irv.12504

Acharya U, Acharya SP. Clinical Outcome of Patients Hospitalized in a Tertiary Care Hospital of Nepal with Confirmed Influenza A/pdm 09(H1N1) in 2018/2019. J Nepal Health Res Counc. 2020;18(2):196-200. DOI: https://doi.org/10.33314/jnhrc.v18i2.2380

Jha BK, Pandit R, Jha R, Manandhar KD. Overview of seasonal influenza and recommended vaccine during the 2016/2017 season in Nepal. Heliyon. 2020;6(1):e03304. DOI: https://doi.org/10.1016/j.heliyon.2020.e03304

Gaitonde DY, Moore USA MC CF, Morgan USA MC MM. Influenza: Diagnosis and Treatment Internet. Available at: https://www.aafp.org/pubs/ afp/issues/2019/1215/p751.pdf. Accessed on 03 June 2025.

Radovanovic D, Sotgiu G, Jankovic M, Mahesh PA, Marcos PJ, Abdalla MI, et al; GLIMP Study Group. An international perspective on hospitalized patients with viral community-acquired pneumonia. Eur J Intern Med. 2019;60:54-70. DOI: https://doi.org/10.1016/j.ejim.2018.10.020

Shrestha N, Karki B, Shrestha PS, Acharya S, Tamang S, Regmi S, et al. A descriptive study of seasonal influenza cases in a single season in a tertiary center in Kathmandu. Grande Med J. 2020;2(1):32–6. DOI: https://doi.org/10.3126/gmj.v2i1.45702

Hood N, Flannery B, Gaglani M, Beeram M, Wernli K, Jackson ML, et al. Influenza vaccine effectiveness among children: 2011-2020. Pediatrics. 2023;151(4):e2022059922. DOI: https://doi.org/10.1542/peds.2022-059922

Barbieri E, Porcu G, Donà D, Cavagnis S, Cantarutti L, Scamarcia A, et al. Epidemiology and Burden of Influenza in Children 0-14 Years Over Ten Consecutive Seasons in Italy. Pediatr Infect Dis J. 2023;42(12):e440-6. DOI: https://doi.org/10.1097/INF.0000000000004090

Boonyaratanakornkit J, Englund JA, Magaret AS, Bu Y, Tielsch JM, Khatry SK, et al. Primary and Repeated Respiratory Viral Infections Among Infants in Rural Nepal. J Pediatric Infect Dis Soc. 2020;9(1):21-9. DOI: https://doi.org/10.1093/jpids/piy107

Albalawi ARS, Alhassun JAS, Almarshud RK, Almejali HA, Alharbi SM, Shaybah AM, et al. Unlocking the power of influenza vaccines for pediatric population: A narrative review. Cureus, 2024;16(2):e55119. DOI: https://doi.org/10.7759/cureus.55119

Orrico-Sánchez A, Valls-Arévalo Á, Garcés-Sánchez M, Álvarez Aldeán J, Ortiz de Lejarazu Leonardo R. Efficacy and effectiveness of influenza vaccination in healthy children. A review of current evidence. Enferm Infecc Microbiol Clin (Engl Ed). 2023;41(7):396-406. DOI: https://doi.org/10.1016/j.eimce.2022.02.016

Regan AK. Munoz FM. Efficacy and safety of influenza vaccination during pregnancy: realizing the potential of maternal influenza immunization. Expert Rev Vaccines. 2021;20(6):649-60. DOI: https://doi.org/10.1080/14760584.2021.1915138

Omer SB, Richards JL, Madhi SA, Tapia MD, Steinhoff MC, Aqil AR, et al. BMGF Supported Maternal Influenza Immunization Trials Investigators Group. Three randomized trials of maternal influenza immunization in Mali, Nepal, and South Africa: Methods and expectations. Vaccine. 2015;33(32):3801-12. DOI: https://doi.org/10.1016/j.vaccine.2015.05.077

Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359(15):1555-64. DOI: https://doi.org/10.1056/NEJMoa0708630

Jarvis JR, Dorey RB, Warricker FDM, Alwan NA, Jones CE. The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: Systematic review and meta-analysis. Vaccine. 2020;38(7):1601-13. DOI: https://doi.org/10.1016/j.vaccine.2019.12.056

Katz J, Englund JA, Steinhoff MC, Khatry SK, Shrestha L, Kuypers J.et al. Impact of Timing of Influenza Vaccination in Pregnancy on Transplacental Antibody Transfer, Influenza Incidence, and Birth Outcomes: A Randomized Trial in Rural Nepal. Clin Infect Dis. 2018;67(3):334-40. DOI: https://doi.org/10.1093/cid/ciy090

Committee on infectious diseases. Recommendations for prevention and control of influenza in children, 2018-2019. Pediatrics. 2018;142(4):e20182367.

Dao CN, Kamimoto L, Nowell M, Reingold A, Gershman K, Meek J, et al. Adult hospitalizations for laboratory-positive influenza during the 2005–2006 through 2007–2008 seasons in the United States. J Infect Dis. 2010;202(6):881–8. DOI: https://doi.org/10.1086/655904

Lu PJ, Hung MC, Srivastav A, Grohskopf LA, Kobayashi M, Harris AM, et al. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018. MMWR Surveill Summ. 2021;70(3):1-26. DOI: https://doi.org/10.15585/mmwr.ss7003a1

Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI, et al. The disease burden of influenza beyond respiratory illness. Vaccine. 2021;39 Suppl 1:A6-A14. DOI: https://doi.org/10.1016/j.vaccine.2020.09.048

Samson SI, Konty K, Lee WN, Quisel T, Foschini L, Kerr D, et al. Quantifying the impact of influenza among persons with type 2 diabetes mellitus: a new approach to determine medical and physical activity impact. J Diabetes Sci Technol. 2019;1932296819883340. DOI: https://doi.org/10.1177/1932296819883340

Horswell R, Chu S, Stone AE, Fort D, Uwaifo G, Fonseca VA, Norton E, et al. Risk of healthcare visits from influenza in subjects with diabetes and impacts of early vaccination. BMJ Open Diabetes Res Care. 2024;12(4):e003841. DOI: https://doi.org/10.1136/bmjdrc-2023-003841

D'Addio F, Lazzaroni E, Lunati ME, Preziosi G, Ercolanoni M, Turola G. et al. Vaccinome landscape in nearly 620,000 patients with diabetes. J Clin Endocrinol Metab. 2024:dgae476. DOI: https://doi.org/10.1210/clinem/dgae476

American Thoracic Society (ATS)/European Respiratory Society Task Force. Standards for the diagnosis and management of patients with COPD version 1.2. Available at www.thoracic.org/copd‐guidelines/. Accessed on 3 June 2025.

British Thoracic Society. COPD guidelines group of the standards of care committee of the BTS. BTS Guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52:S7‐15. DOI: https://doi.org/10.1136/thx.52.2008.S1.5

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD. Available at: https://goldcopd.org/wp-content/uploads/2017/11/ GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf. Accessed on 3 June 2025.

National Institute for Health and Care Excellence (NICE). Chronic obstructive pulmonary disease in over 16s: diagnosis and management. Available at: www.nice.org.uk/guidance/cg101. Accessed on 03 June 2025.

Kopsaftis Z, Wood-Baker R, Poole P. Influenza vaccine for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2018;6(6):CD002733. DOI: https://doi.org/10.1002/14651858.CD002733.pub3

Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999;130:397‐403. DOI: https://doi.org/10.7326/0003-4819-130-5-199903020-00003

Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. Ann Intern Med. 1995;123:518‐27. DOI: https://doi.org/10.7326/0003-4819-123-7-199510010-00008

Macintyre CR, Mahimbo A, Moa AM, Barnes M. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart. 2016;102(24):1953-6. DOI: https://doi.org/10.1136/heartjnl-2016-309983

Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013;310(16):1711–20. DOI: https://doi.org/10.1001/jama.2013.279206

Andrew MK, Gilca V, Waite N, Pereira JA. Examining the knowledge, Attitudes and experiences of Canadian seniors Towards influenza (the EXACT survey). BMC Geriatr. 2019;19(1):178. DOI: https://doi.org/10.1186/s12877-019-1180-5

Wen Y, He L, Zhai Y, Wu J, Chen YY, Wang H, et al. Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39(6):792-98.

Sui HT, Guo Y, Yang ZN, Su JF, Shu X, Zhang Y, et al. Progress in research of influenza vaccine and 23 valent pneumococcal polysaccharide vaccine immunization in patients with chronic obstructive pulmonary disease. Zhonghua Liu Xing Bing Xue Za Zhi. 2022;43(9):1508-12.

de Fougerolles TR, Baïssas T, Perquier G, Vitoux O, Crépey P, Bartelt-Hofer J, et al. Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives. BMC Public Health. 2024;24(1):1222. DOI: https://doi.org/10.1186/s12889-024-18694-5

Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ. et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA. 2000;284(13):1655-63. DOI: https://doi.org/10.1001/jama.284.13.1655

Liu Y, Liu T, Yao M, Wang Q, Li R, Kou Z. Coverage of influenza vaccination and influencing factors among healthcare workers in Shandong Province, China, 2021-2022. Hum Vaccin Immunother. 2024;20(1):2402116. DOI: https://doi.org/10.1080/21645515.2024.2402116

Ledda C, Motta G, Rapisarda V, Maltezou HC. Influenza immunization of healthcare personnel in the post-COVID-19 pandemic era: Still a lot to do! Vaccine: 2023;15(100402):100402. DOI: https://doi.org/10.1016/j.jvacx.2023.100402

Lin CJ, Nowalk MP, Toback SL, Rousculp MD, Raymund M, Ambrose CS, et al. Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults. Vaccine. 2010;28(48):7706–12. DOI: https://doi.org/10.1016/j.vaccine.2010.07.009

Bärnighausen T, Bloom DE, Canning D, O'Brien J. Accounting for the full benefits of childhood vaccination in South Africa. South Afr Med J. 2008;98(11):842-6.

Bärnighausen T, Bloom DE, Cafiero-Fonseca ET, O'Brien JC. Valuing vaccination. Proc Natl Acad Sci. 2014;111(34):12313-9. DOI: https://doi.org/10.1073/pnas.1400475111

Downloads

Published

2025-12-30

How to Cite

Chokhani, R. (2025). Current practices in influenza management and barriers to influenza vaccination in Nepal. International Journal of Research in Medical Sciences, 14(1), 305–311. https://doi.org/10.18203/2320-6012.ijrms20254398

Issue

Section

Review Articles